View original post here:
FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh